Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients

被引:31
作者
Bonato, V. [2 ]
Barni, R. [1 ]
Cataldo, D. [2 ]
Collini, A. [1 ]
Ruggieri, G. [1 ]
De Bartolomeis, C. [1 ]
Dotta, F. [2 ]
Carmellini, M. [1 ]
机构
[1] Azienda Osped Univ Senese, UOC Chirurg Trapianti, I-53100 Siena, Italy
[2] Azienda Osped Univ Senese, UOC Diabetol, I-53100 Siena, Italy
关键词
D O I
10.1016/j.transproceed.2008.05.045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aim. The onset of posttransplant diabetes mellitus (PTDM) among kidney recipients is associated with an increased risk of graft failure and death. Minimizing the risk of PTDM is a priority for long-term improvement in survival rates. We sought to evaluate the prevalence of PTDM and impaired fasting glucose (IFG) among a population of kidney transplant recipients to identify the risk factors and to evaluate graft and patient survivals. Methods. We analyzed 250 consecutive Caucasian patients who received kidney allografts in our center between May 2000 and December 2005, with a median follow-up of 32 months (range, 1.-78 months). Results. We observed altered glucose metabolism in 17% of patients; specifically, the prevalences of PTDM and IFG were 12.2% and 4.8%, respectively. Patients who 2 developed PTDM or IFG were overweight (BMI, 26.4 +/- 3.4 and 28.1. +/- 3.4 kg/m(2) respectively), whereas the normal glucose (NG) group's BMI was 23.8 +/- 3.5 kg/m(2) (P = .002 and P = .004, respectively). Prevalence of acute rejection was higher in the PTDM and IFG patients compared with the NG patients (60.7%, 63.6%, and 32.1%, respectively; P = .006; P < .04), while no difference was observed in terms of graft and patient overall survival. Conclusion. In our series of patients, we showed that being overweight represents a major risk factor for the development of PTDM, which results in an increased acute rejection rate. These results confirmed the importance of appropriate weight control among patients undergoing kidney transplantation, which should also be strictly monitored for all risk factors associated with the development of impaired glucose metabolism.
引用
收藏
页码:1888 / 1890
页数:3
相关论文
共 5 条
  • [1] American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42
  • [2] The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events
    Hjelmesæth, J
    Hartmann, A
    Leivestad, T
    Holdaas, H
    Sagedal, S
    Olstad, M
    Jenssen, T
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (03) : 588 - 595
  • [3] Diabetes mellitus after kidney transplantation in the United States
    Kasiske, BL
    Snyder, JJ
    Gilbertson, D
    Matas, AJ
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (02) : 178 - 185
  • [4] Posttransplantation diabetes - A systematic review of the literature
    Montori, VM
    Basu, A
    Erwin, PJ
    Velosa, JA
    Gabriel, SE
    Kudva, YC
    [J]. DIABETES CARE, 2002, 25 (03) : 583 - 592
  • [5] Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus
    Vincenti, F.
    Friman, S.
    Scheuermann, E.
    Rostaing, L.
    Jenssen, T.
    Campistol, J. M.
    Uchida, K.
    Pescovitz, M. D.
    Marchetti, P.
    Tuncer, M.
    Citterio, F.
    Wiecek, A.
    Chadban, S.
    El-Shahawy, M.
    Budde, K.
    Goto, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) : 1506 - 1514